USANew treatments and approvals
Plozasiran, which lowers triglycerides, approved in the USA for adults with FCS
A decision by a medicines regulator (FDA, European Commission, etc.). The regulator has reviewed the clinical studies behind the drug. For accelerated or conditional approvals, the lasting benefit is still being confirmed.
The FDA approved plozasiran for adults with FCS, in addition to diet. The drug is given as an injection under the skin once every three months. In the trial, triglycerides fell by a median of 59% at month 10. The most common side effects were high blood sugar, headache, nausea and injection-site reactions.
What does it mean for patients and families?
This approval applies only in the USA. Access in Türkiye depends on TİTCK (Turkish Medicines and Medical Devices Agency) and SGK (Social Security Institution) processes. Treatment decisions are made with your doctor.
Source
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Familial chylomicronemia syndrome (FCS)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.